2006 proposed fee schedule - American Society of Clinical Oncology

More documents

Recommendations

Info

ADDENDUM B: RELATIVE VALUE UNITS (RVUs) AND RELATED INFORMATION Physician work Facility PE 1 CPT codes and descriptions only are copyright 2005 American Medical Association. All rights reserved. Applicable FARS/DFARS apply. 2 Copyright 2005 American Dental Association. All rights reserved. 3 +Indicates RVUs are not used for Medicare payment. Mal- practice Nonfacility CPT 1 / HCPCS 2 Mod Status Description RVUs 3 Non-facility Facility PE RVUs RVUs RVUs Total Total Global G0223 I PET imag wholbod reg dx head 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0223 26 I PET imag wholbod reg dx head 1.50 0.54 0.54 0.06 2.10 2.10 XXX G0223 TC I PET imag wholbod reg dx head 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0224 I PET imag wholbod reg ini hea 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0224 26 I PET imag wholbod reg ini hea 1.50 0.54 0.54 0.06 2.10 2.10 XXX G0224 TC I PET imag wholbod reg ini hea 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0225 I PET whol restag headneckonly 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0225 26 I PET whol restag headneckonly 1.50 0.54 0.54 0.06 2.11 2.11 XXX G0225 TC I PET whol restag headneckonly 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0226 I PET img wholbody dx esophagl 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0226 26 I PET img wholbody dx esophagl 1.50 0.55 0.55 0.06 2.12 2.12 XXX G0226 TC I PET img wholbody dx esophagl 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0227 I PET img wholbod ini esophage 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0227 26 I PET img wholbod ini esophage 1.50 0.55 0.55 0.06 2.11 2.11 XXX G0227 TC I PET img wholbod ini esophage 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0228 I PET img wholbod restg esopha 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0228 26 I PET img wholbod restg esopha 1.50 0.54 0.54 0.06 2.10 2.10 XXX G0228 TC I PET img wholbod restg esopha 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0229 I PET img metaboloc brain pres 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0229 26 I PET img metaboloc brain pres 1.50 0.54 0.54 0.06 2.10 2.10 XXX G0229 TC I PET img metaboloc brain pres 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0230 I PET myocard viability post 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0230 26 I PET myocard viability post 1.50 0.55 0.55 0.06 2.12 2.12 XXX G0230 TC I PET myocard viability post 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0231 I PET WhBD colorec; gamma cam 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0231 26 I PET WhBD colorec; gamma cam 1.50 0.54 0.54 0.06 2.10 2.10 XXX G0231 TC I PET WhBD colorec; gamma cam 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0232 I PET whbd lymphoma; gamma cam 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0232 26 I PET whbd lymphoma; gamma cam 1.50 0.55 0.55 0.06 2.11 2.11 XXX G0232 TC I PET whbd lymphoma; gamma cam 0.00 0.00 0.00 0.00 0.00 0.00 XXX
ADDENDUM B: RELATIVE VALUE UNITS (RVUs) AND RELATED INFORMATION CPT 1 / HCPCS 2 Mod Status Description G0233 I PET whbd melanoma; gamma cam G0233 26 I PET whbd melanoma; gamma cam G0233 TC I PET whbd melanoma; gamma cam G0234 I PET WhBD pulm nod; gamma cam G0234 26 I PET WhBD pulm nod; gamma cam G0234 TC I PET WhBD pulm nod; gamma cam Physician work RVUs 3 Non-facility PE RVUs Facility PE RVUs 1 CPT codes and descriptions only are copyright 2005 American Medical Association. All rights reserved. Applicable FARS/DFARS apply. 2 Copyright 2005 American Dental Association. All rights reserved. 3 +Indicates RVUs are not used for Medicare payment. Mal- practice RVUs Nonfacility Total Facility Total Global 0.00 0.00 0.00 0.00 0.00 0.00 XXX 1.50 0.55 0.55 0.06 2.11 2.11 XXX 0.00 0.00 0.00 0.00 0.00 0.00 XXX 0.00 0.00 0.00 0.00 0.00 0.00 XXX 1.50 0.54 0.54 0.06 2.11 2.11 XXX 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0235 N PET not otherwise specified 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0235 26 N PET not otherwise specified 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0235 TC N PET not otherwise specified 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0237 A Therapeutic procd strg endur 0.00 0.40 NA 0.02 0.42 NA XXX G0238 A Oth resp proc, indiv 0.00 0.49 NA 0.00 0.49 NA XXX G0239 A Oth resp proc, group 0.00 0.33 NA 0.00 0.33 NA XXX G0244 E Observ care by facility topt 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0245 R Initial foot exam pt lops 0.88 0.81 0.31 0.04 1.73 1.23 XXX G0246 R Followup eval of foot pt lop 0.45 0.55 0.16 0.02 1.02 0.63 XXX G0247 R Routine footcare pt w lops 0.50 0.55 0.21 0.02 1.07 0.73 ZZZ G0248 R Demonstrate use home inr mon 0.00 6.05 NA 0.01 6.06 NA XXX G0249 R Provide test material,equipm 0.00 3.64 NA 0.01 3.65 NA XXX G0250 R MD review interpret of test 0.18 0.06 0.06 0.01 0.25 0.25 XXX G0251 E Linear acc based stero radio 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0252 N PET imaging initial dx 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0252 26 N PET imaging initial dx 1.50 0.59 0.59 0.04 2.13 2.13 XXX G0252 TC N PET imaging initial dx 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0253 I PET image brst dection recur 0.00 0.00 0.00 0.00 0.00 0.00 XXX G0253 26 I PET image brst dection recur 1.87 0.66 0.66 0.08 2.62 2.62 XXX
Page 1 and 2:
DEPARTMENT OF HEALTH AND HUMAN SERV
Page 3 and 4:
2. By mail. You may mail written co
Page 5 and 6:
Rick Ensor (410) 786-5617 (for issu
Page 7 and 8:
service of the U.S. Government Prin
Page 9 and 10:
4. Proposed Revisions to §413.170
Page 11 and 12:
AGA American Gastroenterological As
Page 13 and 14:
GAO General Accounting Office GPCI
Page 15 and 16:
PLI Professional liability insuranc
Page 17 and 18:
Initially, only the physician work
Page 19 and 20:
This resource-based system was base
Page 21 and 22:
effect in 1997, published on Novemb
Page 23 and 24:
● Revised requirements for superv
Page 25 and 26:
efinement of work RVUs; and solicit
Page 27 and 28:
historical allowed charges. This le
Page 29 and 30:
November 1, 2001 (66 FR 55246).) Th
Page 31 and 32:
The CPEPs identified specific input
Page 33 and 34:
codes that the RUC has not yet revi
Page 35 and 36:
procedure: $27,305,408. In this exa
Page 37 and 38:
as a whole. Indirect costs include
Page 39 and 40:
● The unscaled indirect expense a
Page 41 and 42:
BNF is applied to (multiplied by) t
Page 43 and 44:
NPWP Step 2--Calculation of Charge-
Page 45 and 46:
In Table 11, the scaled total direc
Page 47 and 48:
TABLE 13--Budget Neutrality and Fin
Page 49 and 50:
The following discussion outlines t
Page 51 and 52:
exist, and suggests that the need f
Page 53 and 54:
TABLE 14--Practice Expense Per Hour
Page 55 and 56:
We believe that we have consistentl
Page 57 and 58:
Due to the ongoing refinement by th
Page 59 and 60:
indirect PE methodology is inaccura
Page 61 and 62:
multi-specialty PEAC that were base
Page 63 and 64:
the needed survey or other data or
Page 65 and 66:
PERC/RUC recommendations for these
Page 67 and 68:
eflect the typical number of cast c
Page 69 and 70:
on comments received and additional
Page 71 and 72:
We have reviewed the PE database an
Page 73 and 74:
the ACR. We have accepted the follo
Page 75 and 76:
● Clinical Labor for G-codes Rela
Page 77 and 78:
proposed associated prices that we
Page 79 and 80:
Supply Code Supply Description Unit
Page 81 and 82:
● Supply and Equipment Items Need
Page 83 and 84:
Code 2005 Description Unit Unit Pri
Page 85 and 86:
Code 2005 Description Price EQ212 p
Page 87 and 88:
Effective January 1, 2006, this pro
Page 89 and 90:
challenge the validity of a new loc
Page 91 and 92:
ones reconfigured). Yet we also rec
Page 93 and 94:
The issue of payment locality desig
Page 95 and 96:
specialties listed infrequently as
Page 97 and 98:
for premium rating purposes. ISO co
Page 99 and 100:
psychology to the nonsurgical risk
Page 101 and 102:
to anesthesiology which is 2.84 rat
Page 103 and 104:
103 However, as noted previously in
Page 105 and 106:
● Category #1: Services that are
Page 107 and 108:
G0270, G0271 and 97802 through 9780
Page 109 and 110:
Group Medical Nutritional Therapy (
Page 111 and 112:
111 furnished in the group setting
Page 113 and 114:
CMS Review 113 As noted previously,
Page 115 and 116:
system that permits the physician a
Page 117 and 118:
117 associated with the provided se
Page 119 and 120:
119 overlapping surgeries, the teac
Page 121 and 122:
anesthesia programs that have arran
Page 123 and 124:
123 Section 623 of the MMA also req
Page 125 and 126:
125 hospital-based facilities; whil
Page 127 and 128:
127 The next step would be to devel
Page 129 and 130:
Drugs Second Quarter ASP +6 Percent
Page 131 and 132:
131 independent facilities, to acco
Page 133 and 134:
133
Page 135 and 136:
distributed this over a total proje
Page 137 and 138:
137 additional 0.7 percent addition
Page 139 and 140:
139 billed drugs regardless of sett
Page 141 and 142:
141 than 0.9000 are paid more than
Page 143 and 144:
adoption of the new hospital wage i
Page 145 and 146:
of geographic designations for purp
Page 147 and 148:
and they may or may not be suitable
Page 149 and 150:
the Medicare Geographic Classificat
Page 151 and 152:
(2) Metropolitan Divisions Under OM
Page 153 and 154:
153 applying revised composite paym
Page 155 and 156:
ased on the labor components establ
Page 157 and 158:
157 actual cost structure faced by
Page 159 and 160:
159 ESRD facilities is 53.711, as s
Page 161 and 162:
from the cost reports. To avoid dou
Page 163 and 164:
from Worksheet A. The resulting mar
Page 165 and 166:
(1) Hospital Data Used In this prop
Page 167 and 168:
wage data ended. However, since the
Page 169 and 170:
approach to phasing-in the proposed
Page 171 and 172:
facilities that would receive lower
Page 173 and 174:
173 wage index values and then simu
Page 175 and 176:
175 Because Neighborhood Dialysis C
Page 177 and 178:
177 detected through our receipt of
Page 179 and 180:
179 CBSA Code Urban Area Wage (Cons
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
TABLE 28--Proposed ESRD Wage Index
Page 219 and 220:
● Extraordinary circumstances (§
Page 221 and 222:
effect as long as the rate exceeds
Page 223 and 224:
● Adding a definition of a “ped
Page 225 and 226:
exception rate. The facility would
Page 227 and 228:
their intermediaries. Current parag
Page 229 and 230:
229 costs are reasonable and allowa
Page 231 and 232:
231 revised paragraph, a facility w
Page 233 and 234:
H. Payment for Covered Outpatient D
Page 235 and 236:
calculation. We also discuss the su
Page 237 and 238:
customers (for example, physicians)
Page 239 and 240:
239 We believe the weighted average
Page 241 and 242:
number of 11-digit NDCs sold for ea
Page 243 and 244:
243 included in the template, it is
Page 245 and 246:
current reporting format is an appr
Page 247 and 248:
247 section 1847A of the Act for th
Page 249 and 250:
each quarter at the following web s
Page 251 and 252:
251 We also note MedPAC’s recomme
Page 253 and 254:
costs and units. We seek comments a
Page 255 and 256:
255 pays for DME and associated sup
Page 257 and 258:
pharmacy activities required to get
Page 259 and 260:
259 representing 42 percent of the
Page 261 and 262:
261 basic pharmacy services such as
Page 263 and 264:
seek comment on the potential impac
Page 265 and 266:
265 overpaying for the costs associ
Page 267 and 268:
267 and information about how pharm
Page 269 and 270:
269 takes good faith efforts to res
Page 271 and 272:
271 Specifically, we consider that
Page 273 and 274:
supplies. Using billing data, we id
Page 275 and 276:
70481 CT orbit/ear/fossa w/ dye 704
Page 277 and 278:
K. Therapy Cap 73223 MRI joint uppe
Page 279 and 280:
provided for an active subluxation
Page 281 and 282:
is less than 2 percent of spending
Page 283 and 284:
(2) entities determined by the Secr
Page 285 and 286:
285 We are proposing a supplemental
Page 287 and 288:
FQHC claim form to effectuate the b
Page 289 and 290:
289 can issue a final determination
Page 291 and 292:
291 conclude that Hispanic persons
Page 293 and 294:
293 nuclear medicine services in ei
Page 295 and 296:
adiopharmaceuticals. In the final r
Page 297 and 298:
297 (including Nuclear Medicine and
Page 299 and 300:
we would resolve any doubt on the m
Page 301 and 302:
facility payment rather than a TC c
Page 303 and 304:
ventures and leases, pose a risk of
Page 305 and 306:
305 Underlying the projected rate r
Page 307 and 308:
decisions are central to the health
Page 309 and 310:
however. We are particularly intere
Page 311 and 312:
The collection requirement in this
Page 313 and 314:
eporting requirements are discussed
Page 315 and 316:
IV. Response to Comments Because of
Page 317 and 318:
achieve the objectives with less si
Page 319 and 320:
319 The analysis and discussion pro
Page 321 and 322:
321 for a new code may change becau
Page 323 and 324:
323 TABLE 30--Impact of Practice Ex
Page 325 and 326:
hour for these specialties. As note
Page 327 and 328:
Both physical/occupational therapy
Page 329 and 330:
329 proposing to add cardiology cat
Page 331 and 332:
Speciality Impact of Removing Aberr
Page 333 and 334:
Family TABLE 32--Impact of Multiple
Page 335 and 336:
335 column includes the current est
Page 337 and 338:
Specialty Medicare Allowed Charges
Page 339 and 340:
339 Non-Facility Facility % % HCPCS
Page 341 and 342:
341 have undertaken a similar analy
Page 343 and 344:
of the updated GPCI data. For the R
Page 345 and 346:
C. Medicare Telehealth Services In
Page 347 and 348:
347 TABLE 37--Impact of Proposed Ch
Page 349 and 350:
349 of the increase to the drug add
Page 351 and 352:
plus current AAP priced drug paymen
Page 353 and 354:
353 the center up to what it would
Page 355 and 356:
satisfies the requirements of the i
Page 357 and 358:
357 certainty the extent of these s
Page 359 and 360:
delivery arrangements and would hel
Page 361 and 362:
List of Subjects 42 CFR Part 405 Ad
Page 363 and 364:
(including by refunding amounts in
Page 365 and 366:
(2) Any financial incentives provid
Page 367 and 368:
7. The authority citation for part
Page 369 and 370:
* * * * * PART 413--PRINCIPLES OF R
Page 371 and 372:
371 D. Redesignating paragraphs (l)
Page 373 and 374:
373 (3) The additional nursing hour
Page 375 and 376:
cost components relating to trainin
Page 377 and 378:
CAPD and CCPD) when the facility ac
Page 379 and 380:
Indirect Sales means from the manuf
Page 381 and 382:
amount for the quarter to the neare
Page 383 and 384:
383 25. The heading for Part 426 is
Page 385 and 386:
385 (Catalog of Federal Domestic As
Page 387 and 388:
1. CPT/HCPCS code. This is the CPT
Page 389 and 390:
grace period. This indicator is no
Page 391 and 392:
5. Physician work RVUs. These are t
Page 393 and 394:
ADDENDUM B: RELATIVE VALUE UNITS (R
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
Page 443 and 444:
Page 445 and 446:
Page 447 and 448:
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455 and 456:
Page 457 and 458:
Page 459 and 460:
Page 461 and 462:
Page 463 and 464:
Page 465 and 466:
Page 467 and 468:
Page 469 and 470:
Page 471 and 472:
Page 473 and 474:
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
Page 513 and 514:
Page 515 and 516:
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Page 527 and 528:
Page 529 and 530:
Page 531 and 532:
Page 533 and 534:
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
Page 543 and 544:
Page 545 and 546:
Page 547 and 548:
Page 549 and 550:
Page 551 and 552:
Page 553 and 554:
Page 555 and 556:
Page 557 and 558:
Page 559 and 560:
Page 561 and 562:
Page 563 and 564:
Page 565 and 566:
Page 567 and 568:
Page 569 and 570:
Page 571 and 572:
Page 573 and 574:
Page 575 and 576:
Page 577 and 578:
Page 579 and 580:
Page 581 and 582:
Page 583 and 584:
Page 585 and 586:
Page 587 and 588:
Page 589 and 590:
Page 591 and 592:
Page 593 and 594:
Page 595 and 596:
Page 597 and 598:
Page 599 and 600:
Page 601 and 602:
Page 603 and 604:
Page 605 and 606:
Page 607 and 608:
Page 609 and 610:
Page 611 and 612:
Page 613 and 614:
Page 615 and 616:
Page 617 and 618:
Page 619 and 620:
Page 621 and 622:
Page 623 and 624:
Page 625 and 626:
Page 627 and 628:
Page 629 and 630:
Page 631 and 632:
Page 633 and 634:
Page 635 and 636:
Page 637 and 638:
Page 639 and 640:
Page 641 and 642:
Page 643 and 644:
Page 645 and 646: ADDENDUM B: RELATIVE VALUE UNITS (R
Page 695: ADDENDUM B: RELATIVE VALUE UNITS (R
Page 703 and 704: CPT Code Short Descriptors 21480 Re
Page 705 and 706: CPT Code Short Descriptors 92284 Da
Page 707 and 708: Addendum D 2006 GEOGRAPHIC PRACTICE
Page 709 and 710: Carrier Locality Locality name Work
Page 711 and 712: Carrier Locality Locality Name 2006
Page 713 and 714: Addendum F ESRD FACILITIES- METROPO
Page 715 and 716: 715 SSA State/County Code County an
Page 747 and 748:
747 SSA State/County Code County an
Page 749 and 750:
Page 751 and 752:
Page 753 and 754:
Page 755 and 756:
Page 757 and 758:
Page 759 and 760:
Page 761 and 762:
Page 763 and 764:
Page 765 and 766:
Page 767 and 768:
Page 769 and 770:
Page 771 and 772:
Page 773 and 774:
Page 775 and 776:
Page 777 and 778:
CPT/HCPCS Codes MOD DESCRIPTION STA
Page 779 and 780:
Page 781 and 782:
Page 783 and 784:
Page 785 and 786:
Page 787:
show all

2006 proposed fee schedule - American Society of Clinical Oncology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?